{"id":"https://openalex.org/W2005771217","doi":"https://doi.org/10.1161/01.hyp.10.3.294","title":"Aspirin enhances the antihypertensive effect of captopril in spontaneously hypertensive rats.","display_name":"Aspirin enhances the antihypertensive effect of captopril in spontaneously hypertensive rats.","publication_year":1987,"publication_date":"1987-09-01","ids":{"openalex":"https://openalex.org/W2005771217","doi":"https://doi.org/10.1161/01.hyp.10.3.294","mag":"2005771217","pmid":"https://pubmed.ncbi.nlm.nih.gov/3305356"},"language":"en","primary_location":{"id":"doi:10.1161/01.hyp.10.3.294","doi":"https://doi.org/10.1161/01.hyp.10.3.294","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.hyp.10.3.294","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.10.3.294","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.10.3.294","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008258804","display_name":"Caroline P. Quilley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C P Quilley","raw_affiliation_strings":["C P Quilley"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"C P Quilley","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083221298","display_name":"Satoru Chiba","orcid":"https://orcid.org/0000-0003-0041-6316","observed_orcids":["https://orcid.org/0000-0003-0041-6316","https://orcid.org/0000-0002-1545-3083"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Chiba","raw_affiliation_strings":["S Chiba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S Chiba","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046908555","display_name":"John Quilley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Quilley","raw_affiliation_strings":["J Quilley"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"J Quilley","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109717241","display_name":"J C McGiff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J C McGiff","raw_affiliation_strings":["J C McGiff"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"J C McGiff","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8188,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.61472742,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"10","issue":"3","first_page":"294","last_page":"302"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.7710000276565552,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.7710000276565552,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.10360000282526016,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.09210000187158585,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.921999990940094},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":1.0},{"id":"https://openalex.org/keywords/antihypertensive-effect","display_name":"antihypertensive effect","score":0.8050000071525574},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6710000038146973},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.8799999952316284},{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.781000018119812},{"id":"https://openalex.org/keywords/prostaglandin-f2alpha","display_name":"prostaglandin F2alpha","score":0.9319999814033508},{"id":"https://openalex.org/keywords/urinary-flow","display_name":"urine flow","score":0.8190000057220459},{"id":"https://openalex.org/keywords/water-intake","display_name":"water intake","score":0.8700000047683716},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C2779479957","wikidata":"https://www.wikidata.org/wiki/Q421119","display_name":"Captopril","level":3,"score":0.9742705821990967},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.7430419921875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6351892948150635},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6334275007247925},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5919612050056458},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5647760629653931},{"id":"https://openalex.org/C10146269","wikidata":"https://www.wikidata.org/wiki/Q185557","display_name":"Excretion","level":2,"score":0.5028049945831299},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.4857819378376007},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37320566177368164}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004231","descriptor_name":"Diuresis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004326","descriptor_name":"Drinking","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004573","descriptor_name":"Electrolytes","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011453","descriptor_name":"Prostaglandins","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D011918","descriptor_name":"Rats, Inbred SHR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1161/01.hyp.10.3.294","doi":"https://doi.org/10.1161/01.hyp.10.3.294","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.hyp.10.3.294","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.10.3.294","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},{"id":"pmid:3305356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3305356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension (Dallas, Tex. : 1979)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1161/01.hyp.10.3.294","doi":"https://doi.org/10.1161/01.hyp.10.3.294","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.hyp.10.3.294","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.10.3.294","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2170044055","display_name":"HORMONAL REGULATION OF BLOOD PRESSURE","funder_award_id":"P01HL034300","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G2314676498","display_name":null,"funder_award_id":"HL 25394","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G2630274010","display_name":null,"funder_award_id":"P01 HL 34300-01","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G3471774511","display_name":null,"funder_award_id":"R01 HL 25394-07","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G631129105","display_name":null,"funder_award_id":"R01 HL","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G7194515881","display_name":null,"funder_award_id":"HL 34300-01","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G8094325304","display_name":"Prostaglandins: Kinins and Angiotensin Interactions","funder_award_id":"R01HL025394","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005771217.pdf","grobid_xml":"https://content.openalex.org/works/W2005771217.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W1832651","https://openalex.org/W155434140","https://openalex.org/W223359969","https://openalex.org/W265232755","https://openalex.org/W1237957774","https://openalex.org/W1606919860","https://openalex.org/W1835161419","https://openalex.org/W1853539513","https://openalex.org/W1873146500","https://openalex.org/W1921928991","https://openalex.org/W1924231132","https://openalex.org/W1954780750","https://openalex.org/W1966405405","https://openalex.org/W1967791031","https://openalex.org/W1973465415","https://openalex.org/W1977482543","https://openalex.org/W1983759759","https://openalex.org/W1999994807","https://openalex.org/W2000314850","https://openalex.org/W2025061928","https://openalex.org/W2030022883","https://openalex.org/W2038438180","https://openalex.org/W2039651014","https://openalex.org/W2045323206","https://openalex.org/W2050439834","https://openalex.org/W2053950451","https://openalex.org/W2062116348","https://openalex.org/W2063980915","https://openalex.org/W2067877885","https://openalex.org/W2070095270","https://openalex.org/W2084049478","https://openalex.org/W2089645947","https://openalex.org/W2091698770","https://openalex.org/W2095493062","https://openalex.org/W2101791053","https://openalex.org/W2103139621","https://openalex.org/W2103413038","https://openalex.org/W2106108120","https://openalex.org/W2112800119","https://openalex.org/W2117594247","https://openalex.org/W2310584144","https://openalex.org/W2316814104","https://openalex.org/W2322768603","https://openalex.org/W2327171137","https://openalex.org/W2364130456","https://openalex.org/W2502155705"],"related_works":["https://openalex.org/W1967791031","https://openalex.org/W2773266607","https://openalex.org/W1999841715","https://openalex.org/W1873146500","https://openalex.org/W2019075360","https://openalex.org/W2084049478","https://openalex.org/W2044262494","https://openalex.org/W1999994807","https://openalex.org/W2364130456","https://openalex.org/W1998482143"],"abstract_inverted_index":{"Activation":[0],"of":[1,18,31,37,53,138,174,216,230,242],"renal":[2,217],"or":[3,84,93,208],"vascular":[4],"prostaglandin":[5,152,175,186,218],"mechanisms":[6],"(or":[7],"both)":[8],"has":[9],"been":[10],"proposed":[11],"to":[12,14,70,169,190],"contribute":[13],"the":[15,28,33,51,149,226,238],"antihypertensive":[16],"action":[17],"captopril.":[19],"In":[20,148],"conscious":[21],"spontaneously":[22],"hypertensive":[23],"rats":[24,77],"(SHR)":[25],"studied":[26],"in":[27,76,127,244,255],"established":[29],"phase":[30],"hypertension,":[32],"blood":[34,59,239],"pressure-lowering":[35,240],"effect":[36,223,241,247],"captopril,":[38,210],"30":[39],"mg/kg/12":[40],"hr":[41,165,195],"p.o.":[42],"given":[43],"for":[44],"7":[45],"days,":[46],"was":[47,88,98,104,113,125,142,167,180],"greatly":[48],"enhanced":[49],"by":[50,90,101,110,144,157,200],"addition":[52],"aspirin,":[54],"200":[55],"mg/kg/day":[56],"s.c.":[57],"Systolic":[58],"pressure":[60],"decreased":[61,189],"from":[62],"185":[63],"+/-":[64,68,72,192],"6":[65],"and":[66,82,87,112,140,162,166],"182":[67],"4":[69],"135":[71],"3":[73,129],"mm":[74],"Hg":[75],"treated,":[78],"respectively,":[79],"with":[80,207,251],"captopril":[81,85,102,183,243],"aspirin":[83,94,111,204,236],"alone,":[86],"unaltered":[89],"either":[91,206],"vehicle":[92,150],"alone.":[95],"Water":[96],"intake":[97],"inconsistently":[99],"affected":[100],"but":[103],"increased":[105],"(p":[106,119,196],"less":[107,120,197],"than":[108,121,172,198],"0.01)":[109,199],"even":[114],"higher":[115,171],"after":[116,134],"captopril-aspirin":[117,135],"treatment":[118,146],"0.01).":[122],"Urine":[123],"volume":[124],"elevated":[126],"all":[128],"drug-treated":[130],"groups,":[131],"increasing":[132],"threefold":[133,253],"treatment.":[136],"Excretion":[137],"sodium":[139],"potassium":[141],"unchanged":[143],"any":[145],"regimen.":[147],"group,":[151],"F2":[153,178],"alpha":[154,179],"excretion,":[155,219],"measured":[156],"radioimmunoassay,":[158],"ranged":[159],"between":[160],"65":[161],"93":[163],"ng/8":[164,194],"twofold":[168],"fourfold":[170],"that":[173,248],"E2.":[176],"Prostaglandin":[177],"unaffected":[181],"during":[182],"treatment,":[184,205],"whereas":[185],"E2":[187],"excretion":[188],"12":[191],"2":[193],"Day":[201],"7.":[202],"Long-term":[203],"without":[209],"did":[211],"not":[212],"cause":[213],"sustained":[214],"inhibition":[215],"although":[220],"a":[221,252],"transient":[222],"occurred":[224],"within":[225],"first":[227],"four":[228],"hours":[229],"administration.":[231],"These":[232],"results":[233],"indicate":[234],"1)":[235],"potentiates":[237],"SHR,":[245],"an":[246],"is":[249],"associated":[250],"increase":[254],"urine":[256],"flow.(ABSTRACT":[257],"TRUNCATED":[258],"AT":[259],"250":[260],"WORDS)":[261]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}